Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Ipca Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 882.50 -7.55  | -0.85% 30.11% 21.38 11,146.15
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 882.50 -7.55 -0.85% 886.25 890.05 430,945 861.10 - 890.00
BSE Oct 15, 2019 882.15 -8.00 -0.90% 893.50 890.15 3,499 862.20 - 893.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue-3,745.693,257.763,156.192,867.11 3,144.403,281.77
Other Income-74.6658.0854.7640.77 58.6951.97
Total Income-3,820.353,315.843,210.952,907.88 3,203.093,333.74
Total Expenditure-3,067.422,815.782,740.772,593.42 2,630.332,569.79
Operating Profit-752.93500.06470.18314.46 572.76763.95
Interest-22.2427.5726.9134.56 32.1330.23
PBDT-730.69472.49443.27279.90 540.63733.72
Depreciation-182.42177.73172.95163.26 179.55103.13
PBT & Exceptional Items-548.27294.76270.32116.64 361.08630.59
Exceptional Items----- --
Profit before Tax-548.27294.76270.32116.64 361.08630.59
Provision for Tax-104.2451.1167.5220.44 101.93152.39
Profit after Tax-444.03243.65202.8096.20 259.15478.20
Minority Interest-3.36--- --
Share of Associate--1.81-4.23-8.26-3.06 -4.920.34
Consolidated Profit-445.58239.42194.5493.14 254.23478.54
 
LiabilitiesR Cr
Share Capital-25.2725.2425.2425.24 25.2425.24
Total Reserves-3,097.122,663.012,430.022,233.95 2,183.191,934.42
Shareholder's Funds-3,122.392,688.572,455.262,259.19 2,208.431,959.66
Minority Interest-15.54--- --
Long Term Borrowings-140.85234.01351.74484.27 503.21294.00
Other Non Current Liabilities-172.55185.41196.58178.30 196.36165.45
Current Liabilities-1,097.501,007.57955.93969.95 904.36791.45
Total Debt*-464.95627.56715.75867.18 934.99602.56
Total Liabilities-4,548.834,115.563,959.513,891.71 3,812.363,210.56
 
AssetsR Cr
Net Block-1,940.381,952.961,983.272,014.18 1,800.431,353.59
Non Current Investments-30.0517.5222.2425.82 16.199.00
Other Non-Current Assets-200.65199.60212.18229.79 381.76246.55
Current Investments-90.3869.35113.57- -0.15
Cash and Bank-282.30150.5735.85175.54 124.7976.01
Other Current Assets-2,005.071,725.561,592.401,446.38 1,489.191,525.26
Net Current Assets-1,280.25937.91785.89651.97 709.62809.97
Miscellaneous Exp. Not Written Off----- --
Total Assets-4,548.834,115.563,959.513,891.71 3,812.363,210.56
 
Cash FlowR Cr
From Operations-492.28341.13281.91708.65 468.22522.29
From Investing Activities--156.31-135.40-148.82-218.33 -689.33-369.01
From Finance Activities--183.20-130.41-159.13-461.51 250.54-136.13
Net Inflow/Outflow-152.7775.32-26.0428.81 29.4317.15
 
Key Ratios
Adjusted EPS (Rs)35.2635.2718.9715.427.38 20.1537.92
Adjusted Book Value (Rs)257.49247.12213.02194.55179.02 174.99155.28
Dividend per Share (Rs)-3.001.001.000.00 1.005.00
Cash Flow per Share (Rs)-38.9627.0322.3456.15 37.1041.39
Debt to Equity-0.150.230.290.38 0.420.31
Current Ratio-2.171.931.821.67 1.782.02
ROCE (%)-16.539.949.444.82 13.7827.92
RONW (%)-15.289.478.604.31 12.4327.22
Operating Margin (%)-20.1015.3514.9010.97 18.2223.28
Net Margin (%)-11.627.356.323.31 8.0914.34
Revenue Growth (%)-14.983.2210.08-8.82 -4.1916.96
Net Profit Growth (%)-82.2420.14110.81-62.88 -45.8147.44
EPS Growth (%)-85.8923.07108.87-63.36 -46.8747.90
Book Value Growth (%)-16.159.498.682.30 12.6926.12
 
Market Cues
Close Price (Rs)882.50981.85655.65623.85582.15 635.85844.85
High Price (Rs)1,046.001,046.00695.90644.00887.00 899.30906.85
Low Price (Rs)631.00599.95400.00404.00525.00 592.10493.00
Market Cap (Rs Cr)11,146.1512,415.158,264.847,866.687,316.45 8,058.5010,661.38
Price / Earnings25.0127.8634.5240.4478.55 31.7022.28
Price / Book Value3.433.983.073.203.24 3.655.44
Dividend Yield (%)0.340.310.150.160.00 0.160.59
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
7.35
Piotroski F-Score
8
Modified C-Score
0
5-Years Price to Earnings
21.38
5-Years Price to Book
3.41
Earnings Yield
EBIT / Enterprise value
5.92%
PEG
Price / Earnings to growth ratio
-27.30
Related Stocks
  Current Price   Chng %
Abbott India R10,917.90 -0.74%
Alkem Laboratories R1,915.10 -1.38%
Biocon R260.30 +2.74%
Cadila Healthcare R234.45 +0.75%
Cipla R446.55 +1.28%
Glaxosmithkline Pharma R1,433.15 +2.66%
Lupin R721.15 +0.66%
Pfizer R3,193.15 +0.75%
Piramal Enterprises R1,375.85 -0.05%
Torrent Pharmaceuticals R1,699.85 +0.11%
As on Oct 15, 15:59